GSK IP chief welcomes "balanced" European Competition DG pharma report
As we commented on this blog last week, the European Commission Competition DG report into the use of intellectual property in the pharmaceutical sector was not as bad as many (including us) were fearing it would be. In the next issue of IAM, which…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.